Active surveillance for favorable risk prostate cancer: rationale, risks, and results.

Active surveillance for favorable risk prostate cancer: rationale, risks, and results.

Item
http://www.wikidata.org/entity/Q37019376
Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH databasePredictive models for worsening prognosis in potential candidates for active surveillance of presumed low-risk prostate cancer.Defining the optimal treatment strategy for localized prostate cancer patients: a survey of ongoing studies at the National Cancer Institute of Canada Clinical Trials Group.Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population.Algorithms, nomograms and the detection of indolent prostate cancer.How patients make treatment choices.Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study.Prevention of prostate cancer: what we know and where we are going.Diagnostic and prognostic molecular biomarkers for prostate cancer.Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancerProstate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long-term quality of life and symptom burden.Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment.
P2860

Active surveillance for favorable risk prostate cancer: rationale, risks, and results.

Item
http://www.wikidata.org/entity/Q37019376
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Active surveillance for favorable risk prostate cancer: rationale, risks, and results.
@en
Active surveillance for favorable risk prostate cancer: rationale, risks, and results.
@nl
type
label
Active surveillance for favorable risk prostate cancer: rationale, risks, and results.
@en
Active surveillance for favorable risk prostate cancer: rationale, risks, and results.
@nl
prefLabel
Active surveillance for favorable risk prostate cancer: rationale, risks, and results.
@en
Active surveillance for favorable risk prostate cancer: rationale, risks, and results.
@nl
P1433
P1476
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Active surveillance for favorable risk prostate cancer: rationale, risks, and results.
@en
P304
P31
P356
10.1016/J.UROLONC.2007.05.021
P433
P478
P50
P577
P698